Table 1

Baseline participant characteristics and 11478G→A genotype in the ELSA (n=1805) and Whitehall II (n=2733) studies

GGGA/AAp Value
ELSA (wave 0, 2001)
 Men n (%)724 (46.5%)112 (45.0%)0.46
 Age (years)61.6 (61.4 to 62.3)61.5 (60.4 to 62.6)0.74
 FEV1 (litres)2.56 (2.52 to 2.60)2.56 (2.47 to 2.65)0.94
 FEV1 (% predicted)89 (87 to 90)90 (87 to 92)0.48
 FVC (litres)3.26 (3.21 to 3.31)3.26 (3.15 to 3.38)0.97
 Smoking (pack-years)*19.3 (18.4 to 20.3)18.6 (16.2 to 21.0)0.58
 BMI (kg m−2)27.7 (27.4 to 27.9)27.3 (26.6 to 27.9)0.28
 Current smoker %15.015.80.58
Whitehall II (phase 7, 2002–2004)
 Men n (%)1726 (86.6)648 (87.7)0.44
 Age (years)61.3 (60.9 to 61.8)60.9 (60.7 to 61.1)0.10
 FEV1 (litres)2.94 (2.86 to 3.01)2.92 (2.90 to 2.95)0.59
 FEV1 (% predicted)77 (76 to 78)77 (77 to 77)0.93
 FVC (litres)3.93 (3.85 to 4.02)3.91 (3.87 to 3.94)0.57
 Smoking (pack-years)6.72 (6.01 to 7.42)6.30 (6.02 to 6.58)0.28
 BMI (kg m−2)26.8 (26.4 to 27.1)26.8 (26.6 to 26.9)0.96
 Current smoker %13.312.20.68
  • Data are expressed as means (95% CI) adjusted for age in linear regression for continuous variables and number (percentage) for categorical variables. Analyses are limited to those participants with lung function data from two time points.

  • * Calculated in ever smokers.

  • BMI, body mass index; ELSA, English Longitudinal Study of Ageing; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity.